Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interferon”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchUnknownNCT04293887
What this trial is testing

Efficacy and Safety of IFN-α2β in the Treatment of Novel Coronavirus Patients

Who this might be right for
COVID-19Recombinant Human Interferon α1β
Tongji Hospital 328
Not applicableStudy completedNCT00947609
What this trial is testing

Improving Latent Tuberculosis (TB) Diagnosis in Thai Children

Who this might be right for
Latent TuberculosisHIV Infections
SEARCH Research Foundation 158
Large-scale testing (Phase 3)Study completedNCT04356495
What this trial is testing

Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation

Who this might be right for
Corona Virus InfectionSars-CoV2
University Hospital, Bordeaux 412
Post-approval studies (Phase 4)Study completedNCT01142466
What this trial is testing

A Phase IV Study of Rebif ® 44mcg Administered Three Times Per Week by Subcutaneous Injection Compared With no Treatment in the Therapy of Relapsing Multiple Sclerosis After Mitoxantrone

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Merck KGaA, Darmstadt, Germany 30
Testing effectiveness (Phase 2)Study completedNCT02068222
What this trial is testing

Evaluate the Safety and Antiviral Effect of ABT-450/Ritonavir and ABT-530 Coadministered With and Without Ribavirin in Adults With Genotype 3 Hepatitis C (HCV) Infection

Who this might be right for
Chronic Hepatitis CHepatitis C Virus
AbbVie 10
Large-scale testing (Phase 3)Study completedNCT01292239
What this trial is testing

A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected Patients

Who this might be right for
Hepatitis C, Chronic
Janssen Pharmaceutical K.K. 183
Not applicableStudy completedNCT01280656
What this trial is testing

A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 660
Not applicableEnded earlyNCT01904201
What this trial is testing

Evaluation of a Blood Test to Measure Immune Function in HIV Positive People Compared With HIV Negative People

Who this might be right for
HIV Positive
QIAGEN Gaithersburg, Inc 57
Testing effectiveness (Phase 2)Study completedNCT00842114
What this trial is testing

Rituximab and CVP Plus Interferon for Follicular Non Hodgkins Lymphoma (NHL)

Who this might be right for
Non-Hodgkin's Lymphoma
Fundación Leucemia y Linfoma, Spain 50
Testing effectiveness (Phase 2)Study completedNCT00528528
What this trial is testing

An Open-Label Study of Telaprevir Administered Every 12 or 8 Hours in Combination With One of Two Pegylated Interferons and Ribavirin in Treatment-Naive Genotype 1 Chronic Hepatitis C Participants

Who this might be right for
Chronic Hepatitis C
Tibotec BVBA 166
Testing effectiveness (Phase 2)Study completedNCT01878799
What this trial is testing

Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV

Who this might be right for
Hepatitis CHIV
National Institute of Allergy and Infectious Diseases (NIAID) 50
Early research (Phase 1)Study completedNCT00728936
What this trial is testing

Placebo-controlled, Dose-escalation Study of the Safety of IMO-2125 (Immunomodulatory Oligonucleotide) in Hepatitis C-infected Patients

Who this might be right for
Hepatitis C
Idera Pharmaceuticals, Inc. 58
Large-scale testing (Phase 3)Study completedNCT05028634
What this trial is testing

Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Celgene 63
Not applicableEnded earlyNCT01716403
What this trial is testing

Telaprevir Exposure and Severe Anemia in HCV Infected Patients Treated by Tri-therapy

Who this might be right for
C Hepatitis, Tri Therapy
University Hospital, Grenoble 8
Large-scale testing (Phase 3)Study completedNCT01281839
What this trial is testing

An Efficacy, Safety and Tolerability Study of TMC435 in Genotype 1 Hepatitis C-infected Patients Who Relapsed After Previous Therapy

Who this might be right for
Hepatitis C
Janssen R&D Ireland 394
Not applicableStudy completedNCT01986712
What this trial is testing

Compare Quality of Life and Compliance in Patients Receiving High-dose Interferon Versus Pegylated Interferon in Patients With Surgically Resected Melanoma

Who this might be right for
Melanoma
St. Luke's Hospital and Health Network, Pennsylvania 50
Post-approval studies (Phase 4)Study completedNCT00207311
What this trial is testing

Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus

Who this might be right for
Fatty LiverHepatitis C
Brooke Army Medical Center 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07840287
What this trial is testing

A Long-Term Extension (LTE) Study Of Enpatoran In Cutaneous Manifestations Of Lupus With Or Without Systemic Disease [Elowen-LTE]

Who this might be right for
Systemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
EMD Serono Research & Development Institute, Inc. 404
Testing effectiveness (Phase 2)Study completedNCT02124044
What this trial is testing

Safety, Tolerability, and Efficacy of Asunaprevir and Daclatasvir in Subjects Coinfected With HIV-HCV

Who this might be right for
HIV-HCV
National Institutes of Health Clinical Center (CC) 30
Testing effectiveness (Phase 2)Study completedNCT00001509
What this trial is testing

A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor

Who this might be right for
NephroblastomaNeuroblastoma
National Cancer Institute (NCI) 60
Next Page